7LGD
HLA-B*07:02 in complex with SARS-CoV-2 nucleocapsid peptide N105-113
Summary for 7LGD
Entry DOI | 10.2210/pdb7lgd/pdb |
Descriptor | HLA class I histocompatibility antigen, B alpha chain, Beta-2-microglobulin, SARS-CoV-2 nucleocapsid peptide N105-113, ... (7 entities in total) |
Functional Keywords | sars-cov-2, hla, t cell, cross-reactivity, covid-19, antigen presentation, immune system |
Biological source | Homo sapiens (Human) More |
Total number of polymer chains | 6 |
Total formula weight | 91400.72 |
Authors | Gras, S.,Szeto, C.,Chatzileontiadou, D.S.M. (deposition date: 2021-01-20, release date: 2021-04-21, Last modification date: 2023-10-18) |
Primary citation | Lineburg, K.E.,Grant, E.J.,Swaminathan, S.,Chatzileontiadou, D.S.M.,Szeto, C.,Sloane, H.,Panikkar, A.,Raju, J.,Crooks, P.,Rehan, S.,Nguyen, A.T.,Lekieffre, L.,Neller, M.A.,Tong, Z.W.M.,Jayasinghe, D.,Chew, K.Y.,Lobos, C.A.,Halim, H.,Burrows, J.M.,Riboldi-Tunnicliffe, A.,Chen, W.,D'Orsogna, L.,Khanna, R.,Short, K.R.,Smith, C.,Gras, S. CD8 + T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses. Immunity, 54:1055-, 2021 Cited by PubMed: 33945786DOI: 10.1016/j.immuni.2021.04.006 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.88 Å) |
Structure validation
Download full validation report